Market Overview:
The global pharmaceutical fermenter market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for biopharmaceuticals and rising investments in R&D by pharmaceutical companies. In terms of type, the self-priming liquid fermenter segment is expected to lead the global pharmaceutical fermenter market during the forecast period. This segment is projected to grow at a CAGR of 6% from 2018 to 2030.
Product Definition:
A Pharmaceutical Fermenter is a vessel used in the production of pharmaceuticals. The importance of Pharmaceutical Fermenters is that they allow for the controlled fermentation of pharmaceutical products.
Self-priming Liquid Fermenter:
Self-priming liquid fermenters are used to produce biopharmaceuticals such as vaccines, monoclonal antibodies, and therapeutic proteins. The growing demand for these products is expected to drive the market over the forecast period.
The self-priming liquid fermenters have advantages such as it can be used in different temperature ranges which include room temperature up to 40°C and refrigerated temperatures below 4°C.
Mechanical Agitation Fermenter:
Mechanical agitation fermenter is used in pharmaceutical fermentation process. It helps to mix the culture medium with the solid or liquid food materials and keep them moving for a certain period of time so that they can be evenly distributed and broken down into an edible form.
Application Insights:
The others application segment includes hospital, commercial production, and research centers. The other applications include the ones that are not covered under the current fermentation technologies such as biopharmaceuticals and small molecules. The laboratory application segment accounted for a major share in 2015 owing to extensive usage of pharmaceutical fermenters for growing bacteria required for various clinical trials.
Pharmaceutical manufacturers use these devices to grow large numbers of bacterial cultures needed to conduct multi-step processes including protein expression and purification from cell culture supernatants or by using recombinant DNA techniques. These devices also offer flexibility in changing conditions such as temperature, pH, and volume which helps maintain quality control during process steps involved in drug discovery & development leading to an overall increase in market demand over the forecast period.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market over the forecast period. The presence of a large number of pharmaceutical and biotechnology companies in countries, such as China, India, South Korea and Japan is anticipated to drive the growth. In addition, factors such as increasing R&D activities by domestic companies coupled with government support are likely to contribute toward this region’s growth during the forecast period.
In 2016, North America accounted for a revenue share of around 25% owing to high investments in R&D by domestic players coupled with favorable regulations regarding drug development processes pertaining towards FDA approval. Furthermore, growing demand for generic drugs due to increased healthcare expenditure in this region has led major manufacturers based out there focus on product innovation through research & development activities resulting into an increase in global fermentser consumption within this region over time.
The Middle East & Africa (MEA) market was valued at USD X million in 2017.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global pharmaceutical fermenter market is expected to grow at a CAGR of 5.5% from 2016 to 2021, owing to the increasing demand for biopharmaceuticals. Biopharmaceuticals are produced through fermentation and are used in the treatment of various diseases such as cancer, diabetes, and autoimmune disorders.
- Technological advancements: The pharmaceutical fermenter market is witnessing rapid technological advancements with the introduction of novel products and processes that are helping manufacturers reduce production costs and improve product quality. For instance, in 2015, Sartorius Stedim Biotech introduced its STEDIM FERMENTOR 100 system that offers high flexibility and reproducibility for small-scale fermentation processes. This system helps reduce process time by up to 50%.
- Rising R&D expenditure: Pharmaceutical companies are investing heavily in R&D activities to develop new drugs that can be used for the treatment of various diseases such as cancer, Alzheimer’s disease, and heart failure. This is driving the growth of the pharmaceutical fermenter market as these companies require large-scale fermentation systems for drug development purposes. In 2015, Roche invested US$ 9 billion in R&D activities which was more than any other company worldwide4 .
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Fermenter Market Research Report
By Type
Self-priming Liquid Fermenter, Mechanical Agitation Fermenter
By Application
Laboratory, Research Center, Others
By Companies
Sartorius, Eppendorf, Bioengineering, DCI-Biolafitte, Colepamer, Infors, MARUBISHI, Guoqiang, Baoxing, Eastbio, Yabao, Shenger
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
167
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Fermenter Market Report Segments:
The global Pharmaceutical Fermenter market is segmented on the basis of:
Types
Self-priming Liquid Fermenter, Mechanical Agitation Fermenter
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Research Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sartorius
- Eppendorf
- Bioengineering
- DCI-Biolafitte
- Colepamer
- Infors
- MARUBISHI
- Guoqiang
- Baoxing
- Eastbio
- Yabao
- Shenger
Highlights of The Pharmaceutical Fermenter Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Self-priming Liquid Fermenter
- Mechanical Agitation Fermenter
- By Application:
- Laboratory
- Research Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Fermenter Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pharmaceutical fermenter is a device used to produce antibiotics, vaccines and other medications.
Some of the key players operating in the pharmaceutical fermenter market are Sartorius, Eppendorf, Bioengineering, DCI-Biolafitte, Colepamer, Infors, MARUBISHI, Guoqiang, Baoxing, Eastbio, Yabao, Shenger.
The pharmaceutical fermenter market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Fermenter Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Fermenter Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Fermenter Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Fermenter Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Fermenter Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Fermenter Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Fermenter Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Fermenter Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Fermenter Market Size Forecast by Type
5.2.1 Self-priming Liquid Fermenter
5.2.2 Mechanical Agitation Fermenter
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Fermenter Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Fermenter Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 Research Center
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Fermenter Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Fermenter Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Fermenter Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Fermenter Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Fermenter Market Size Forecast by Type
9.6.1 Self-priming Liquid Fermenter
9.6.2 Mechanical Agitation Fermenter
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Fermenter Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 Research Center
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Fermenter Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Fermenter Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Fermenter Market Size Forecast by Type
10.6.1 Self-priming Liquid Fermenter
10.6.2 Mechanical Agitation Fermenter
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Fermenter Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 Research Center
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Fermenter Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Fermenter Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Fermenter Market Size Forecast by Type
11.6.1 Self-priming Liquid Fermenter
11.6.2 Mechanical Agitation Fermenter
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Fermenter Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 Research Center
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Fermenter Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Fermenter Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Fermenter Market Size Forecast by Type
12.6.1 Self-priming Liquid Fermenter
12.6.2 Mechanical Agitation Fermenter
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Fermenter Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 Research Center
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Fermenter Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Fermenter Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Fermenter Market Size Forecast by Type
13.6.1 Self-priming Liquid Fermenter
13.6.2 Mechanical Agitation Fermenter
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Fermenter Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 Research Center
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Fermenter Market: Competitive Dashboard
14.2 Global Pharmaceutical Fermenter Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sartorius
14.3.2 Eppendorf
14.3.3 Bioengineering
14.3.4 DCI-Biolafitte
14.3.5 Colepamer
14.3.6 Infors
14.3.7 MARUBISHI
14.3.8 Guoqiang
14.3.9 Baoxing
14.3.10 Eastbio
14.3.11 Yabao
14.3.12 Shenger
